News for Mersana Therapeutics, Inc. (MRSN)

Published at

Mar 3, 2025 2:00 PM

by gurufocus.com

positive

positive

Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results

Announced positive initial Phase 1 clinical data and an additional Fast Track designation for Emi-LeInitiated first expansion cohort in patients with triple-neg

MRSN JNJ DJNJ3.BA DJNJ2.BA

Read more →
Published at

Mar 3, 2025 1:56 PM

by gurufocus.com

mixed

mixed

Mersana Therapeutics Inc Reports Q4 EPS of -$0.15 and Revenue of $7.68 Million, Meeting Estimates

Revenue: Reported $7.68 million for the fourth quarter, meeting the estimated revenue of $7.68 million.Earnings Per Share (EPS): Reported EPS of -$0.15, meetin

MRSN JNJ DJNJ3.BA DJNJ2.BA

Read more →
Published at

Feb 25, 2025 3:00 PM

by gurufocus.com

positive

positive

Mersana Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. ( MRSN), a clinical-stage biopharmaceutical company focused on discovering and

MRSN

Read more →
Published at

Feb 24, 2025 11:00 PM

by gurufocus.com

positive

positive

Mersana Therapeutics to Host Fourth Quarter and Year End 2024 Conference Call on March 3, 2025

CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. ( MRSN), a clinical-stage biopharmaceutical company focused on discovering and

MRSN

Read more →
Published at

Feb 7, 2025 10:13 PM

by manilatimes.net

positive

positive

Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

**media[535325]**

MRSN

Read more →
Published at

Jan 18, 2025 1:30 AM

by investing.com

positive

positive

Mersana Therapeutics' chief accounting officer sells shares worth $2,061 By Investing.com

Mersana Therapeutics' chief accounting officer sells shares worth $2,061

MRSN

Read more →
Published at

Jan 18, 2025 1:28 AM

by investing.com

positive

positive

Mersana therapeutics director Anna Protopapas sells shares worth $5,009 By Investing.com

Mersana therapeutics director Anna Protopapas sells shares worth $5,009

MRSN

Read more →
Published at

Jan 18, 2025 1:27 AM

by investing.com

positive

positive

Mersana Therapeutics officer Timothy Lowinger sells $4,667 in stock By Investing.com

Mersana Therapeutics officer Timothy Lowinger sells $4,667 in stock

MRSN

Read more →
Published at

Jan 18, 2025 1:23 AM

by investing.com

positive

positive

Mersana Therapeutics CEO sells $2,618 in stock By Investing.com

Mersana Therapeutics CEO sells $2,618 in stock

MRSN

Read more →
Published at

Jan 18, 2025 1:21 AM

by investing.com

positive

positive

Mersana Therapeutics' SVP sells shares worth $4,912 By Investing.com

Mersana Therapeutics' SVP sells shares worth $4,912

MRSN

Read more →
Published at

Jan 18, 2025 1:19 AM

by investing.com

positive

positive

Mersana Therapeutics chief development officer sells shares worth $3,444 By Investing.com

Mersana Therapeutics chief development officer sells shares worth $3,444

MRSN

Read more →
Published at

Jan 10, 2025 12:32 PM

by manilatimes.net

positive

positive

Mersana Therapeutics Announces Additional FDA Fast Track Designation Granted to Emiltatug Ledadotin (XMT-1660)

**media[511543]**

MRSN

Read more →
Published at

Jan 10, 2025 12:11 PM

by manilatimes.net

positive

positive

Mersana Therapeutics Announces Positive Initial Clinical Data from Phase 1 Clinical Trial of Emiltatug Ledadotin (XMT-1660); Initiation of Expansion in Triple Negative Breast Cancer

**media[511519]**

MRSN JNJ DJNJ3.BA DJNJ2.BA

Read more →
Published at

Dec 19, 2024 1:17 PM

by seekingalpha.com

neutral

neutral

Mersana Therapeutics: We're About To Find Out If ADC Platform Is More Tolerable (MRSN)

Mersana Therapeutics is utilizing antibody-drug conjugates to target new immune checkpoints and revolutionize cancer treatment. See why MRSN looks interesting now.

MRSN

Read more →
Published at

Dec 4, 2024 9:32 AM

by investing.com

mixed

mixed

Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications By Investing.com

Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications

ILU.DE ILMN.MX ILMN I1LM34.SA 0J8Z.L MRSN MGNX AMGN

Read more →
Published at

Nov 4, 2024 6:36 PM

by investing.com

mixed

mixed

Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC By Investing.com

Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC

NTIV.SW LONN.SW MRSN MGNX AMGN

Read more →
Published at

Oct 15, 2024 5:01 PM

by gurufocus.com

positive

positive

SILVERARC CAPITAL MANAGEMENT, LLC Reduces Stake in Mersana Therapeutics Inc

On October 11, 2024, SILVERARC CAPITAL MANAGEMENT, LLC (Trades, Portfolio) executed a significant transaction by reducing its holdings in Mersana Therapeutics I

URGN RNA MRSN 0XOD.L

Read more →
Published at

Jun 10, 2024 8:18 PM

by investing.com

positive

positive

Pyxis Oncology adds biopharma veteran to board By Investing.com

Pyxis Oncology adds biopharma veteran to board

SNDX MRSN CTIC

Read more →
Published at

Jun 10, 2024 1:30 PM

by globenewswire.com

neutral

neutral

Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger

BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation...

SNDX MRSN CTIC

Read more →
Published at

Jan 18, 2024 7:08 PM

by benzinga.com

mixed

mixed

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session - Agrify (NASDAQ:AGFY), Acasti Pharma (NASDAQ:ACST)

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents.

TSMN.MX TSM.BA TSM SAVE RAMP PLUN.DE PLUG.MX PLUG PHUNW PHUN PCSA NVVEW NVVE NUKK MRSN MMAT MIMO MDC DFS.MX DFS DC7.DE D1FS34.SA CUTR CURO CELU AKTS AGFY 2330.TW 0L8U.L 0JW5.L 0IBC.L USBC34.SA USB.SN USB.MX USB.BA USB UB5.DE PRQR LICY JBLU HUM.MX HUM FVIN.MX FVI.TO FSM EHTH DADA CANO ARAV ACST.V ACST 0QYM.L 0LHY.L 0J6Z.L SIFY MSCL.SN HTZZ HTZGQ HTZ 0J4Z.L

Read more →